Highly potent and isoform-selective dual-site-binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have anti-proliferative activity

Amit Nathubhai; Teemu Haikarainen; Jarkko Koivunen; Sudarshan Murthy; Francoise Koumanov; Matthew Lloyd; Geoffrey Holman; Taina Pihlajaniemi; David Tosh; Lari Lehtio; Michael Threadgill

doi:10.1021/acs.jmedchem.6b01574

Highly potent and isoform-selective dual-site-binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have anti-proliferative activity

Amit Nathubhai
, Teemu Haikarainen
, Jarkko Koivunen
, Sudarshan Murthy
, Francoise Koumanov
, Matthew Lloyd
, Geoffrey Holman
, Taina Pihlajaniemi
, David Tosh
, Lari Lehtio
, Michael Threadgill

University of Oulu

Research output: Contribution to journal › Article › peer-review

55 Citations (SciVal)

512 Downloads (Pure)

Abstract

Compounds 13 and 14 were evaluated against eleven PARP isoforms to reveal that both 13 and 14 were more potent and isoform-selective towards inhibiting tankyrases (TNKSs) than the “standard” inhibitor 1 (XAV939)5, i.e. IC50 = 100 pM vs. TNKS2 and IC50 = 6.5 µM vs. PARP1 for 14. In cellular assays, 13 and 14 inhibited Wnt-signaling, enhanced insulin-stimulated glucose uptake and inhibited the proliferation of DLD-1 colorectal adenocarcinoma cells to a greater extent than 1.

Original language	English
Pages (from-to)	814-820
Number of pages	7
Journal	Journal of Medicinal Chemistry
Volume	60
Issue number	2
Early online date	16 Dec 2016
DOIs	https://doi.org/10.1021/acs.jmedchem.6b01574
Publication status	Published - 26 Jan 2017

Access to Document

10.1021/acs.jmedchem.6b01574

Nathubhai_Just_accepted_proof_revisions.pdf
This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Medicinal Chemistry, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see 10.1021/acs.jmedchem.6b01574.
Accepted author manuscript, 920 KB

Role of Rab3 in Peripheral Tissue Insulin Resistance
Koumanov, F. (PI), Betts, J. (CoI), Gonzalez, J. (CoI), Thompson, D. (CoI) & Whitley, P. (CoI)
MRC
1/12/16 → 31/07/20
Project: Research council
Elucidation of Final Stages in Coupling of Insulin Signalling to CLUT4 Translocation
Holman, G. (PI) & Koumanov, F. (CoI)
MRC
1/07/12 → 30/06/15
Project: Research council
Role of TBC11D1 in Heart Cell Insulin Resistance
Holman, G. (PI) & Koumanov, F. (CoI)
British Heart Foundation
1/09/11 → 30/11/13
Project: UK charity

David Tosh
- D.Toshbath.acuk
Person: Research & Teaching, Affiliate staff

MC2- Nuclear Magnetic Resonance (NMR)
Material and Chemical Characterisation (MC2)
Facility/equipment: Technology type
MC2- X-ray diffraction (XRD)
Material and Chemical Characterisation (MC2)
Facility/equipment: Technology type

Cite this

Nathubhai, A., Haikarainen, T., Koivunen, J., Murthy, S., Koumanov, F., Lloyd, M., Holman, G., Pihlajaniemi, T., Tosh, D., Lehtio, L., & Threadgill, M. (2017). Highly potent and isoform-selective dual-site-binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have anti-proliferative activity. Journal of Medicinal Chemistry, 60(2), 814-820. https://doi.org/10.1021/acs.jmedchem.6b01574

Highly potent and isoform-selective dual-site-binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have anti-proliferative activity. / Nathubhai, Amit; Haikarainen, Teemu; Koivunen, Jarkko et al.
In: Journal of Medicinal Chemistry, Vol. 60, No. 2, 26.01.2017, p. 814-820.

Research output: Contribution to journal › Article › peer-review

Nathubhai, A, Haikarainen, T, Koivunen, J, Murthy, S, Koumanov, F , Lloyd, M , Holman, G, Pihlajaniemi, T, Tosh, D, Lehtio, L & Threadgill, M 2017, 'Highly potent and isoform-selective dual-site-binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have anti-proliferative activity', Journal of Medicinal Chemistry, vol. 60, no. 2, pp. 814-820. https://doi.org/10.1021/acs.jmedchem.6b01574

@article{75c6427984ae4146a8401decdf51f55f,

title = "Highly potent and isoform-selective dual-site-binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have anti-proliferative activity",

abstract = "Compounds 13 and 14 were evaluated against eleven PARP isoforms to reveal that both 13 and 14 were more potent and isoform-selective towards inhibiting tankyrases (TNKSs) than the “standard” inhibitor 1 (XAV939)5, i.e. IC50 = 100 pM vs. TNKS2 and IC50 = 6.5 µM vs. PARP1 for 14. In cellular assays, 13 and 14 inhibited Wnt-signaling, enhanced insulin-stimulated glucose uptake and inhibited the proliferation of DLD-1 colorectal adenocarcinoma cells to a greater extent than 1.",

author = "Amit Nathubhai and Teemu Haikarainen and Jarkko Koivunen and Sudarshan Murthy and Francoise Koumanov and Matthew Lloyd and Geoffrey Holman and Taina Pihlajaniemi and David Tosh and Lari Lehtio and Michael Threadgill",

year = "2017",

month = jan,

day = "26",

doi = "10.1021/acs.jmedchem.6b01574",

language = "English",

volume = "60",

pages = "814--820",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "2",

}

TY - JOUR

T1 - Highly potent and isoform-selective dual-site-binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have anti-proliferative activity

AU - Nathubhai, Amit

AU - Haikarainen, Teemu

AU - Koivunen, Jarkko

AU - Murthy, Sudarshan

AU - Koumanov, Francoise

AU - Lloyd, Matthew

AU - Holman, Geoffrey

AU - Pihlajaniemi, Taina

AU - Tosh, David

AU - Lehtio, Lari

AU - Threadgill, Michael

PY - 2017/1/26

Y1 - 2017/1/26

N2 - Compounds 13 and 14 were evaluated against eleven PARP isoforms to reveal that both 13 and 14 were more potent and isoform-selective towards inhibiting tankyrases (TNKSs) than the “standard” inhibitor 1 (XAV939)5, i.e. IC50 = 100 pM vs. TNKS2 and IC50 = 6.5 µM vs. PARP1 for 14. In cellular assays, 13 and 14 inhibited Wnt-signaling, enhanced insulin-stimulated glucose uptake and inhibited the proliferation of DLD-1 colorectal adenocarcinoma cells to a greater extent than 1.

AB - Compounds 13 and 14 were evaluated against eleven PARP isoforms to reveal that both 13 and 14 were more potent and isoform-selective towards inhibiting tankyrases (TNKSs) than the “standard” inhibitor 1 (XAV939)5, i.e. IC50 = 100 pM vs. TNKS2 and IC50 = 6.5 µM vs. PARP1 for 14. In cellular assays, 13 and 14 inhibited Wnt-signaling, enhanced insulin-stimulated glucose uptake and inhibited the proliferation of DLD-1 colorectal adenocarcinoma cells to a greater extent than 1.

U2 - 10.1021/acs.jmedchem.6b01574

DO - 10.1021/acs.jmedchem.6b01574

M3 - Article

SN - 0022-2623

VL - 60

SP - 814

EP - 820

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 2

ER -

Highly potent and isoform-selective dual-site-binding tankyrase/Wnt signaling inhibitors that increase cellular glucose uptake and have anti-proliferative activity

Abstract

Access to Document

Fingerprint

Projects

Role of Rab3 in Peripheral Tissue Insulin Resistance

Elucidation of Final Stages in Coupling of Insulin Signalling to CLUT4 Translocation

Role of TBC11D1 in Heart Cell Insulin Resistance

Profiles

David Tosh

Equipment

MC2- Nuclear Magnetic Resonance (NMR)

MC2- X-ray diffraction (XRD)

Cite this